FHA
TEVA icon

First Horizon Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

First Horizon Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$24.1K Sell
1,436
-3
-0.2% -$48 ﹤0.01% 1344
2025
Q1 		$22.1K Sell
1,439
-160
-10% -$2.86K ﹤0.01% 1286
2024
Q4 		$35.2K Sell
1,599
-53
-3% -$964 ﹤0.01% 1095
2024
Q3 		$29.8K Buy
1,652
+504
+44% +$8.82K ﹤0.01% 1213
2024
Q2 		$18.7K Buy
1,148
+963
+521% +$14.8K ﹤0.01% 1303
2024
Q1 		$2.61K Sell
185
-139
-43% -$1.75K ﹤0.01% 1968
2023
Q4 		$3.38K Hold
324
– – ﹤0.01% 1889
2023
Q3 		$3.3K Buy
324
+61
+23% +$568 ﹤0.01% 1865
2023
Q2 		$1.98K Hold
263
– – ﹤0.01% 2072
2023
Q1 		$2.33K Hold
263
– – ﹤0.01% 2057
2022
Q4 		$2.4K Buy
263
+78
+42% +$681 ﹤0.01% 2016
2022
Q3 		$1K Hold
185
– – ﹤0.01% 2188
2022
Q2 		$1K Buy
+185
New +$1.61K ﹤0.01% 2273
2022
Q1 		– Sell
-185
Closed -$1K – 2260
2021
Q4 		$1K Hold
185
– – ﹤0.01% 2165
2021
Q3 		$1K Buy
185
+149
+414% +$1.4K ﹤0.01% 2192
2021
Q2 		$0 Hold
36
– – ﹤0.01% 2091
2021
Q1 		$0 Hold
36
– – ﹤0.01% 1987
2020
Q4 		$0 Buy
+36
New +$345 ﹤0.01% 1574
2019
Q3 		– Sell
-285
Closed -$2K – 1635
2019
Q2 		$2K Sell
285
-2,069
-88% -$24.9K ﹤0.01% 1404
2019
Q1 		$36K Buy
2,354
+69
+3% +$1.22K ﹤0.01% 613
2018
Q4 		$35K Sell
2,285
-299
-12% -$6.13K ﹤0.01% 596
2018
Q3 		$55K Sell
2,584
-148
-5% -$3.44K ﹤0.01% 554
2018
Q2 		$66K Buy
2,732
+2,347
+610% +$47.9K 0.01% 524
2018
Q1 		$6K Hold
385
– – ﹤0.01% 1172
2017
Q4 		$7K Sell
385
-732
-66% -$11K ﹤0.01% 1134
2017
Q3 		$19K Sell
1,117
-175
-14% -$3.94K ﹤0.01% 809
2017
Q2 		$39K Buy
1,292
+33
+3% +$1.02K ﹤0.01% 555
2017
Q1 		$40K Buy
1,259
+249
+25% +$8.5K ﹤0.01% 591
2016
Q4 		$46K Hold
1,010
– – 0.01% 552
2016
Q3 		$46K Sell
1,010
-252
-20% -$13.1K 0.01% 546
2016
Q2 		$64K Sell
1,262
-1,476
-54% -$78.6K 0.01% 467
2016
Q1 		$147K Sell
2,738
-784
-22% -$46K 0.02% 361
2015
Q4 		$231K Buy
3,522
+1,850
+111% +$114K 0.04% 252
2015
Q3 		$94K Buy
1,672
+82
+5% +$5.32K 0.01% 407
2015
Q2 		$94K Sell
1,590
-68
-4% -$4.2K 0.01% 416
2015
Q1 		$103K Buy
1,658
+242
+17% +$14.1K 0.01% 413
2014
Q4 		$82K Buy
1,416
+14
+1% +$780 0.01% 443
2014
Q3 		$75K Buy
1,402
+13
+0.9% +$689 0.01% 444
2014
Q2 		$72K Buy
1,389
+449
+48% +$22.9K 0.01% 473
2014
Q1 		$49K Sell
940
-49
-5% -$2.27K 0.01% 515
2013
Q4 		$39K Buy
989
+188
+23% +$7.4K 0.01% 537
2013
Q3 		$30K Buy
801
+452
+130% +$17.6K ﹤0.01% 562
2013
Q2 		$14K Buy
+349
New +$13.6K 0.01% 439

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

First Horizon Advisors's TEVA Position: Q2 2025 in Review

First Horizon Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 0.21% in Q2 2025, selling an estimated $48 and leaving 1,436 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1344.

First Horizon Advisors first reported a position in TEVA in Q2 2013 and has held it in 43 quarters since. The position peaked at $231K in Q4 2015. 540 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • First Horizon Advisors held 1,436 shares of Teva Pharmaceuticals worth $24.1K as of Q2 2025.
  • First Horizon Advisors sold 3 Teva Pharmaceuticals shares in Q2 2025, an estimated $48.
  • Teva Pharmaceuticals made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1344 holding.
  • First Horizon Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 43 quarters since.
  • First Horizon Advisors's Teva Pharmaceuticals position peaked at $231K in Q4 2015.
  • 540 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.